Skip to Main Content

Paper Details

<i>CDKN2A</i> deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS).
Haematologica
12
2021
Author NameAffiliation
Daniel LeongamornlertWellcome Sanger Institute
Jorge ZamoraCIMUS - Molecular Medicine and Chronic Diseases Research Centre, University of Santiago de Compostela.
Adam ButlerWellcome Sanger Institute
Inigo MartincorenaWellcome Sanger Institute
Peter J CampbellWellcome Sanger Institute
  • 1 - 5

Datasets

Release 1.2